“Veterinarian of the Year 2024” winner of the WVA Global Veterinary Awards
One Health champion Dr Simon Doherty is recognised as “Veterinarian of the Year 2024” of the WVA Global Veterinary Awards supported by Ceva Santé Animale.
Winner of Veterinary Education category of the 2024 World Veterinary Association Global Veterinary Award
The World Veterinary Association (WVA) and Ceva Santé Animale (Ceva) are pleased to announce the winner of the Veterinary Education category in the forthcoming WVA Global Veterinary Awards, as Professor Dato’ Dr. Azmi Lila based in Malaysia.
Winner of Animal Welfare category of the 2024 World Veterinary Association Global Veterinary Awards
The World Veterinary Association (WVA) and Ceva Santé Animale (Ceva) are pleased to announce the winner of the Animal Welfare category in the forthcoming WVA Global Veterinary Awards, as Dr. Sheilah Robertson, based in Gainesville, Florida, United States.
Canadian veterinarian Dr Shane Renwick is the winner of Medicine Stewardship category of the WVA Global Veterinary Awards
Dr. Renwick is the second category winner to be announced in the run up to the Awards ceremony which will take place on the 17th of April during the 39th World Veterinary Association Congress (WVAC), in Cape Town, South Africa.
Northern Ireland veterinarian Dr. Simon Doherty is the winner of One Health category of the WVA Global Veterinary Awards
Dr. Doherty is the first category winner to be announced in the run up to the Awards ceremony which will take place on the 17th of April during the 39th World Veterinary Association Congress (WVAC), in Cape Town, South Africa.
Ceva Santé Animale announces new leadership for North America
Ceva is pleased to announce the appointment of Brad McCollum as Senior Vice President for North America.
Ceva Santé Animale announces Japan-based joint venture with Mitsui
The French leading animal health company has formed a joint venture with one of the largest Japanese conglomerates to accelerate the expansion of the veterinary laboratory to Japan, a key market for the business.
Ceva celebrates 100 years of developing animal vaccines at its Dessau site in Germany
Over the last 100 years this site has greatly contributed to the discovery of effective vaccines and serums to improve animal health.
Ceva launched sow vaccine against neonatal diarrhoea with 7 antigens inside
Enteroporc Coli AC offers the broadest protection against the 7 most relevant antigens in neonatal diarrhoea in a single vaccine.
Ceva: Calculator compares acid cost with vaccine cost
Ceva provides a calculator to compare the individual on-farm treatment cost with acids for sows and pigs with the potential vaccination costs for the same target groups.
Ceva´s vaccine against pandemic swine Flu, RESPIPORC Flupan H1N1 given extra claim for sows
The extension of the claim to sows and gilts offers producers a significant economic benefit to further vaccination against flu strains.
Ceva receives positive opinion from EMA for Circovac® + Hyogen® Ready to Mix: DUO™ swine vaccines
The combination of products gives protection against PCV2 and Mycoplasma hyopneumoniae until 26 weeks of age.
Ceva and INRAE: Research and innovation in animal health
Framework agreement aimed at consolidating collaboration in animal health, the prevention of infectious diseases of animal origin, and the improvement of animal welfare.
Ceva webinar focuses on new approach to zinc oxide ban
Webinar aims to help vets and farmers initiate effective programmes to control disease before zinc oxide is withdrawn.
Interactive map from Ceva tracks swine flu across Europe
A new service which will help farmers and vets track a serious pig disease across much of Europe has been launched by Ceva.
Ceva Santé Animale announces the winners of the Global Animal Welfare Awards
The World Veterinary Association (WVA) and Ceva Santé Animale are delighted to announce the winners of the 4th annual Global Animal Welfare Awards.
Ceva opens new reference for autogenous vaccine manufacture
Ceva builds on its preventative health strategy with the opening of a new European reference for the manufacture of autogenous vaccines.
Ceva launches ForcerisTM across Europe
European Patent Office decides in Ceva’s favour, clearing the way for the launch of ForcerisTM across Europe.
Ceva returns to strong double-digit growth in 2019 and reveals plans to double sales by 2025
Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019 as the company returned to strong double-digit growth (+14.6%).
Ceva reorganizes its shareholding structure, new long-term partners and existing investors to secure the group’s independent future
Ceva Santé Animale today announced that it has renewed its shareholding structure, welcoming leading international investors to join long-term partners, who will invest alongside management to secure the continued independent development of the group.
Ceva commits to improving preventative health strategies for Vietnam’s rapidly growing livestock sector
Ceva Santé Animale signed several agreements with the Vietnam Department of Animal Health (DAH) to accelerate the implementation of preventive health strategies, including the research and development of new vaccines for Vietnamese livestock sector.
Welcome to 333
Connect, share, and interact with the largest community of professionals in the swine industry.
Celebrating 137837Users on 333!
Sign upAlready a member?Recommended accounts
Other - China
Company - Canada
Company - Germany
Company - France